ECONOMIC EFFICIENCY OF NONCOMMUNICABLE DISEASE PREVENTION PROGRAMS IN THE HEALTHCARE SYSTEM

The article provides a detailed analysis of the economic effectiveness of programs for the prevention of noncommunicable diseases (NCDs), such as cardiovascular, diabetic, oncological pathologies and chronic diseases of the respiratory system. These conditions are the dominant causes of morbidity and mortality in the modern world, imposing serious burdens on national health protection systems and the economies of States. The study includes a thorough discussion of NCDs prevention strategies, from behavioral modification and early detection of diseases to training programs and government projects aimed at maintaining the health of citizens. An estimated analysis of various prevention practices was carried out from the point of view of economic benefits, considering not only investments and the costs of their deployment, but also possible long–term advantages — reducing the cost of therapeutic measures, preventing disability, improving the quality of life and extending the life span. The article evaluates national and local healthcare systems using up-to-date statistical information and global samples. The authors of the article paid special attention to comparing methods for assessing economic efficiency, including tools such as cost-benefit analysis (CBA), cost-effectiveness analysis (CEA), and predictive modeling of the long-term economic consequences of preventive measures. In the course of the work, cases of effective national standards for the prevention of NCDs from various countries were considered, which helped to identify key aspects contributing to an increase in the effect of the implementation of such measures.